Pharma Group Renews Bid To Halt Pfizer-Wyeth Deal

Law360, New York (October 16, 2009, 1:08 PM EDT) -- A group of California pharmacies and pharmacists has picked up the sword again in its fight to block Pfizer Inc.’s proposed $68 billion buyout of rival Wyeth, filing an amended complaint after a judge ruled the plaintiffs had failed to support their claims that the merger will eliminate competition and stifle innovation in the U.S. prescription drug market.

The group, which buys drugs from Pfizer and Wyeth, lodged its first amended complaint in the U.S. District Court for the Northern District of California on Friday after...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.